Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.
Journal: Cephalalgia : an international journal of headache
Published: April 07, 2026
Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine.
Journal: Headache
Published: May 19, 2023
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi-center study.
Journal: Headache
Published: September 09, 2021
Safety and tolerability of preventive treatment options for chronic migraine.
Journal: Expert opinion on drug safety
Published: June 15, 2021
Headache secondary to cerebrovascular disease.
Journal: Cephalalgia : an international journal of headache
Published: March 19, 2021
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
Journal: Journal of primary care & community health
Published: September 28, 2020
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
Journal: Headache
Published: July 12, 2019
Triptans for Migraine Patients With Vascular Risks: New Insights, New Options.
Journal: Headache
Published: June 08, 2019
What Are We Missing in the Diagnostic Criteria for Migraine?
Journal: Current pain and headache reports
Published: October 07, 2018
Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.
Journal: The journal of headache and pain
Published: October 01, 2018
Last Updated: 09/26/2026